KalVista Pharmaceuticals (KALV) Interest Coverage Ratio Growth (3y) (2020 - 2025)
KalVista Pharmaceuticals (KALV) Interest Coverage Ratio Growth (3y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -42.41% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 28.11% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -6.89% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 79.27% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 29.47% |
| 10 | KalVista Pharmaceuticals | 1.36 Bn | 1.36 Bn | 49.41 Mn | -96.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | -96.38% |
| Oct 31, 2024 | -38.53% |
| Jul 31, 2024 | 10.00% |
| Apr 30, 2024 | 34.60% |
| Jan 31, 2024 | 53.79% |
| Oct 31, 2023 | 56.80% |
| Jul 31, 2023 | 59.63% |
| Jan 31, 2023 | 29.59% |
| Oct 31, 2022 | 21.24% |
| Jul 31, 2022 | 65.66% |
| Apr 30, 2022 | 56.61% |
| Jan 31, 2022 | 51.42% |
| Oct 31, 2021 | 45.11% |
| Jul 31, 2021 | 28.08% |
| Jan 31, 2021 | -23.37% |
| Oct 31, 2020 | -13.08% |
| Jul 31, 2020 | -60.12% |
| Apr 30, 2020 | 74.49% |